| Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The Company’s assets and liabilities measured at fair value on a recurring basis, excluding the assets and liabilities of CIP discussed in Note 15, as of June 30, 2026 and December 31, 2025 by fair value hierarchy level were as follows: June 30, 2026 | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 140,120 | | | $ | — | | | $ | — | | | $ | 140,120 | | | Investment securities - fair value | | | | | | | | | Sponsored funds | 27,923 | | | — | | | — | | | 27,923 | | | Equity securities | 19,004 | | | — | | | — | | | 19,004 | | | Debt securities | — | | | 2,773 | | | — | | | 2,773 | | | | | | | | | | | Nonqualified retirement plan assets | 30,582 | | | — | | | — | | | 30,582 | | | Total assets measured at fair value | $ | 217,629 | | | $ | 2,773 | | | $ | — | | | $ | 220,402 | | | | | | | | | | | Liabilities | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 114,697 | | | $ | 114,697 | | | Total liabilities measured at fair value | $ | — | | | $ | — | | | $ | 114,697 | | | $ | 114,697 | |
December 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 340,276 | | | $ | — | | | $ | — | | | $ | 340,276 | | | Investment securities - fair value | | | | | | | | | Sponsored funds | 51,013 | | | — | | | — | | | 51,013 | | | Equity securities | 22,903 | | | — | | | — | | | 22,903 | | | Debt securities | — | | | 2,546 | | | — | | | 2,546 | | | | | | | | | | | Nonqualified retirement plan assets | 20,090 | | | — | | | — | | | 20,090 | | | Total assets measured at fair value | $ | 434,282 | | | $ | 2,546 | | | $ | — | | | $ | 436,828 | | | | | | | | | | | Liabilities | | | | | | | | | Contingent consideration | $ | — | | | $ | — | | | $ | 20,800 | | | $ | 20,800 | | | Total liabilities measured at fair value | $ | — | | | $ | — | | | $ | 20,800 | | | $ | 20,800 | |
The assets and liabilities of CIP measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025 by fair value hierarchy level were as follows: | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 103,659 | | | $ | — | | | $ | — | | | $ | 103,659 | | | Debt investments | 79 | | | 2,505,853 | | | 27,172 | | | 2,533,104 | | | Equity investments | 55,016 | | | 186 | | | 145 | | | 55,347 | | | Derivatives | 756 | | | 119 | | | — | | | 875 | | | Total assets measured at fair value | $ | 159,510 | | | $ | 2,506,158 | | | $ | 27,317 | | | $ | 2,692,985 | | | Liabilities | | | | | | | | | Notes payable | $ | — | | | $ | 2,311,391 | | | $ | — | | | $ | 2,311,391 | | | Derivatives | 319 | | | 125 | | | — | | | 444 | | | | | | | | | | | Total liabilities measured at fair value | $ | 319 | | | $ | 2,311,516 | | | $ | — | | | $ | 2,311,835 | |
| | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | | (in thousands) | Level 1 | | Level 2 | | Level 3 | | Total | | Assets | | | | | | | | | Cash equivalents | $ | 86,491 | | | $ | — | | | $ | — | | | $ | 86,491 | | | Debt investments | 91 | | | 2,536,337 | | | 30,333 | | | 2,566,761 | | | Equity investments | 66,180 | | | — | | | 411 | | | 66,591 | | | | | | | | | | | Total assets measured at fair value | $ | 152,762 | | | $ | 2,536,337 | | | $ | 30,744 | | | $ | 2,719,843 | | | Liabilities | | | | | | | | | Notes payable | $ | — | | | $ | 2,359,828 | | | $ | — | | | $ | 2,359,828 | | | | | | | | | | | Derivatives | 225 | | | — | | | — | | | 225 | | | Total liabilities measured at fair value | $ | 225 | | | $ | 2,359,828 | | | $ | — | | | $ | 2,360,053 | |
|
| Schedule of Liabilities of Consolidated Sponsored Investment Products For Level 3 Investments, Unobservable Inputs Used to Determine Fair Value |
The following table presents a reconciliation of beginning and ending balances of the Company's contingent consideration liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (in thousands) | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | Contingent consideration, beginning of period | $ | 118,344 | | | $ | 23,014 | | | $ | 20,800 | | | $ | 36,100 | | | Additions for acquisition | — | | | — | | | 109,420 | | | — | | | | | | | | | | | Adjustments for payments | 760 | | | — | | | (11,525) | | | (13,086) | | | Increase (reduction) of liability related to re-measurement of fair value | (4,407) | | | (3,014) | | | (3,998) | | | (3,014) | | | Contingent consideration, end of period | $ | 114,697 | | | $ | 20,000 | | | $ | 114,697 | | | $ | 20,000 | |
|